At the IGTP TODAY
An international team of researchers identifies the genetic basis and biological processes that influence cancer risk related to alterations in the number of immune cells present in blood. This is a significant advance in the understanding of how the immune system can prevent the appearance of tumours.
Two studies by CEEISCAT with the PISCIS cohort show that people living with HIV have been less vaccinated with the full initial regimen against COVID-19
The European Union's project THRIVE held its kick-off meeting on 12 January 2024 in Barcelona. The project is coordinated by Josep M. Llovet (IDIBAPS). IGTP collaborates as a partner through c-LOG, led by Carolina Armengol.
Researchers from B·ARGO and the Urological Tumour Unit at IGTP and ICO have led a study proposing a new therapeutic strategy based on a combination of kinase inhibitors for metastatic prostate cancer patients who have progressed on standard treatment. The study has been published in the journal Frontiers in Pharmacology.
Research teams from BSC-CNS, UPV/EHU and IGTP are working on a project that uses artificial intelligence to predict and prevent type 2 diabetes. This initiative is part of the Complementary Plan for Biotechnology Applied to Health, coordinated by IBEC.
The 'Retina Stroke Code' acts against a type of stroke that can cause irreversible vision loss if not addressed within 6 hours. It is unique in Catalonia and has proven crucial over five years for recovering visual acuity and preventing worse complications in patients at Germans Trias Hospital.
_1705911882.jpeg)
The Germans Trias i Pujol Research Institute (IGTP) has received funding to develop four projects as part of the "Public-Private Collaboration Projects" call by the State Research Agency of the Ministry of Science and Innovation, amounting to a total of €1,706,019.92.
The network IMMUNO-model has brought together researchers and innovators from all over the world to foster research in immuno-oncology through the advancement in the development and implementation of pre-clinical models. This initiative is funded by the European Cooperation in Science and Technology (COST) programme.
Two studies by CEEISCAT-IGTP have evaluated an online HIV and HCV self-testing strategy, demonstrating that it is effective and safe.
Institutions in and around the Can Ruti Campus have come together to develop Innomed, a programme aimed at sharing skills, knowledge, and resources to boost innovation. The initiative has recently received support from the ITEMAS platform.
